Melinta, Part 2 / Bankruptcy is not the end / Post-approval costs for an antibiotic
Dear All, I realized after sending the note about Melinta’s bankruptcy that I’d failed to be clear on what comes next for the company. (If you missed it, you can go here for a copy of that prior note.) In brief, a 27 Dec 2019 press release (link) states that the bankruptcy filing exchanges $140 million of secured claims
7 January 2020 No Comments